Literature DB >> 19410015

Current and past smoking significantly increase risk for Barrett's esophagus.

Kylie J Smith1, Suzanne M O'Brien, Adèle C Green, Penelope M Webb, David C Whiteman.   

Abstract

BACKGROUND & AIMS: Barrett's esophagus (BE) is the precursor to esophageal adenocarcinoma; the incidence of this cancer is rapidly increasing in Western populations. However, few population-based studies of BE have been conducted, so little is known about potentially modifiable causes of this disease.
METHODS: The study included patients with newly diagnosed BE, confirmed by histology and categorized as simple BE (without dysplasia, n = 285) or dysplastic BE (with dysplasia, n = 108). We recruited 2 separate control groups: endoscopy patients with acute inflammatory changes (inflammation controls, n = 313) and population controls sampled from a population register (n = 644). Data were collected through standardized questionnaires and telephone interviews. We fit logistic regression models to calculate odds ratios (ORs) for BE associated with salient exposures by using each set of controls.
RESULTS: Relative to never smokers, risks of simple BE were significantly higher among former smokers (OR, 2.39; 95% confidence interval, 1.59-3.60) and current smokers (OR, 2.41; 95% confidence interval, 1.39-4.17), compared with population controls. Smoking conferred more than a 4-fold increase in risk for dysplastic BE; this increase in risk remained long after individuals quit smoking. We found no conclusive association between BE and passive smoking and no evidence of independent associations between body mass index (BMI) and simple BE or dysplastic BE, after adjusting for reflux and other factors. Analyses with inflammation controls produced qualitatively similar risk estimates for smoking and BMI to those obtained for population controls, but they were markedly attenuated for reflux, as expected.
CONCLUSIONS: Current and past smoking significantly increases risk for BE, but BMI does not, after adjustment for the effect of reflux.

Entities:  

Mesh:

Year:  2009        PMID: 19410015     DOI: 10.1016/j.cgh.2009.04.018

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  24 in total

1.  High intake of folate from food sources is associated with reduced risk of esophageal cancer in an Australian population.

Authors:  Torukiri I Ibiebele; Maria Celia Hughes; Nirmala Pandeya; Zhen Zhao; Grant Montgomery; Nick Hayward; Adèle C Green; David C Whiteman; Penelope M Webb
Journal:  J Nutr       Date:  2010-12-22       Impact factor: 4.798

2.  Helicobacter pylori infection and the risks of Barrett's oesophagus: a population-based case-control study.

Authors:  Aaron P Thrift; Nirmala Pandeya; Kylie J Smith; Adèle C Green; Nicholas K Hayward; Penelope M Webb; David C Whiteman
Journal:  Int J Cancer       Date:  2011-08-17       Impact factor: 7.396

Review 3.  Recent developments in pathogenesis, diagnosis and therapy of Barrett's esophagus.

Authors:  Magnus Halland; David Katzka; Prasad G Iyer
Journal:  World J Gastroenterol       Date:  2015-06-07       Impact factor: 5.742

4.  No significant effects of smoking or alcohol consumption on risk of Barrett's esophagus.

Authors:  Aaron P Thrift; Jennifer R Kramer; Peter A Richardson; Hashem B El-Serag
Journal:  Dig Dis Sci       Date:  2013-10-11       Impact factor: 3.199

5.  Cigarette smoking increases risk of Barrett's esophagus: an analysis of the Barrett's and Esophageal Adenocarcinoma Consortium.

Authors:  Michael B Cook; Nicholas J Shaheen; Lesley A Anderson; Carol Giffen; Wong-Ho Chow; Thomas L Vaughan; David C Whiteman; Douglas A Corley
Journal:  Gastroenterology       Date:  2012-01-11       Impact factor: 22.682

6.  Smoking and Barrett's esophagus in women who undergo upper endoscopy.

Authors:  Brian C Jacobson; Edward L Giovannucci; Charles S Fuchs
Journal:  Dig Dis Sci       Date:  2011-03-30       Impact factor: 3.199

Review 7.  Role of chemoprophylaxis with either NSAIDs or statins in patients with Barrett's esophagus.

Authors:  Panagiotis Tsibouris; Erasmia Vlachou; Peter Edward Thomas Isaacs
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-02-06

Review 8.  A review of the epidemiology of Barrett's oesophagus and oesophageal adenocarcinoma.

Authors:  Jennifer L Schneider; Douglas A Corley
Journal:  Best Pract Res Clin Gastroenterol       Date:  2014-12-03       Impact factor: 3.043

Review 9.  Influence of obesity on the risk of esophageal disorders.

Authors:  Jesper Lagergren
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-06       Impact factor: 46.802

Review 10.  Barrett's Esophagus and Esophageal Adenocarcinoma: How Common Are They Really?

Authors:  Aaron P Thrift
Journal:  Dig Dis Sci       Date:  2018-08       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.